NovaMed Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Lahore · Pakistan
Lahore-based pharmaceutical manufacturer and marketer with local, toll-manufacturing and export operations across multiple dosage forms.
NovaMed Pharmaceuticals products in Pakistan
NovaMed Pharmaceuticals(Pvt.)Ltd has 185 medicine presentations registered in Pakistan under 74 brands, covering 61 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Hematology & thrombosis. Its brands with the most registered strengths and packs are Taboxa (Rivaroxaban), Ciprojan (Ciprofloxacin), O-Zole (Omeprazole) and Arithro (Clarithromycin). 185 products have an official DRAP price on MedInfoBase. See all 74 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- NovaMed Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- 28-KM Ferozpur Road, Lahore, Pakistan
- Website
- novamed.com.pk ↗
- Phone
- +92 42 35403360-4
- info@novamed.com.pk
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Oct 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where NovaMed Pharmaceuticals(Pvt.)Ltd is priced against the market
170 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Acinopril Plus | Lisinopril | 20 mg | Tablet | 28's | 076830 | PKR 916.10 | PKR 32.72/tablet | 🔒 Pharma Pro |
| Alar | Artemether | 20 mg | Tablet | 1x16's | 049421 | PKR 660.76 | PKR 41.30/tablet | 🔒 Pharma Pro |
| Alar DS | Artemether | 40 mg | Tablet | 1x8's | 059909 | PKR 545.14 | PKR 68.14/tablet | 🔒 Pharma Pro |
| Alar Once | Artemether | 80 mg | Dispersible tablet | 1x6's | 059901 | PKR 681.41 | PKR 113.57/tablet | No comparator |
| Alar Once | Artemether | 80 mg | Dispersible tablet | 1x4's | 059901 | PKR 454.29 | PKR 113.57/tablet | No comparator |
| Alar Plus | Artemether | 40 mg | Dispersible tablet | 1x8's | 059902 | PKR 545.14 | PKR 68.14/tablet | No comparator |
| Aldezole | Metronidazole | 500 mg/100 mL | IV infusion | 1's(100ml) | 078720 | PKR 189.93 | — | No comparator |
| Amilip | Amlodipine | 5 mg | Tablet | 20's | 043467 | PKR 216.82 | PKR 10.84/tablet | 🔒 Pharma Pro |
| Amilip | Amlodipine | 5 mg | Tablet | 10x10's | 043467 | PKR 997.35 | PKR 9.97/tablet | 🔒 Pharma Pro |
| Amilip | Amlodipine | 10 mg | Tablet | 20's | 043468 | PKR 410.92 | PKR 20.55/tablet | 🔒 Pharma Pro |
| Amilip | Amlodipine | 10 mg | Tablet | 10x10's | 043468 | PKR 1,776.47 | PKR 17.76/tablet | 🔒 Pharma Pro |
| Arithro | Clarithromycin | 250 mg | Tablet | 1x10's | 043478 | PKR 495.57 | PKR 49.56/tablet | 🔒 Pharma Pro |
| Arithro | Clarithromycin | 250 mg | Tablet | 100's | 043478 | PKR 4,286.82 | PKR 42.87/tablet | 🔒 Pharma Pro |
| Arithro | Clarithromycin | 500 mg | Tablet | 100's | 043479 | PKR 8,453.71 | PKR 84.54/tablet | 🔒 Pharma Pro |
| Arithro | Clarithromycin | 500 mg | Tablet | 10's | 043479 | PKR 918.88 | PKR 91.89/tablet | 🔒 Pharma Pro |
| Arithro | Clarithromycin | 125 mg/5 mL | Dry suspension | 60ml | 047947 | PKR 460.47 | PKR 7.67/mL | 🔒 Pharma Pro |
| Arithro | Clarithromycin | 500 mg | Lyophilized injection | 1's | 110978 | PKR 456.82 | PKR 456.82/vial/unit | No comparator |
| B-Loc | Atenolol | 50 mg | Tablet | 2x10's | 043466 | PKR 161.05 | PKR 8.05/tablet | 🔒 Pharma Pro |
| B-Loc | Atenolol | 50 mg | Tablet | 100's | 043466 | PKR 695.68 | PKR 6.96/tablet | 🔒 Pharma Pro |
| B-Loc | Atenolol | 100 mg | Tablet | 2x10's | 043471 | PKR 217.62 | PKR 10.88/tablet | 🔒 Pharma Pro |
| B-Loc | Atenolol | 100 mg | Tablet | 100's | 043471 | PKR 941.20 | PKR 9.41/tablet | 🔒 Pharma Pro |
| B-Loc | Atenolol | 25 mg | Tablet | 2x10's | 076825 | PKR 116.21 | PKR 5.81/tablet | 🔒 Pharma Pro |
| Babic | Cephalexin | 500 mg | Capsule | 12's | 043476 | PKR 294.31 | PKR 24.53/capsule | 🔒 Pharma Pro |
| Babic | Cephalexin | 250 mg | Capsule | 12's | 043482 | PKR 149.29 | PKR 12.44/capsule | 🔒 Pharma Pro |
| Babic | Cephalexin | 125 mg/5 mL | Suspension | 60ml | 043486 | PKR 108.77 | PKR 1.81/mL | 🔒 Pharma Pro |
| Babic | Cephalexin | 250 mg/5 mL | Suspension | 60ml | 043493 | PKR 189.82 | PKR 3.16/mL | 🔒 Pharma Pro |
| C-Doxil Capsules 500mgRegistry verified | Cefadroxil as monohydrate | — | — | — | 043492Official source ↗ | No indexed price | — | — |
| C-Doxil Suspension 125mg/5mlRegistry verified | Cefadroxil as monohydrate | — | — | — | 043491Official source ↗ | No indexed price | — | — |
| C-Doxil Suspension 250mgRegistry verified | Cefadroxil as monohydrate | — | — | — | 043499Official source ↗ | No indexed price | — | — |
| Cefcin | Ceftriaxone | 250 mg | Injection | 1's | 045036 | PKR 201.42 | PKR 201.42/vial/unit | 🔒 Pharma Pro |
| Cefcin | Ceftriaxone | 500 mg | Injection | 1's | 045037 | PKR 339.03 | PKR 339.03/vial/unit | 🔒 Pharma Pro |
| Cefcin | Ceftriaxone | 1 g | Injection | 1's | 045038 | PKR 640.17 | PKR 640.17/vial/unit | 🔒 Pharma Pro |
| Cefcin | Ceftriaxone | 250 mg | Injection | 1's | 100874 | PKR 162.18 | PKR 162.18/vial/unit | 🔒 Pharma Pro |
| Cefcin | Ceftriaxone | 500 mg | Injection | 1's | 100875 | PKR 272.97 | PKR 272.97/vial/unit | 🔒 Pharma Pro |
| Cefcin | Ceftriaxone | 1 g | Injection | 1's | 100876 | PKR 515.44 | PKR 515.44/vial/unit | 🔒 Pharma Pro |
| Ciprojan | Ciprofloxacin | 250 mg | Tablet | 1x10's | 043487 | PKR 268.44 | PKR 26.84/tablet | 🔒 Pharma Pro |
| Ciprojan | Ciprofloxacin | 250 mg | Tablet | 10x10's | 043487 | PKR 2,064.90 | PKR 20.65/tablet | 🔒 Pharma Pro |
| Ciprojan | Ciprofloxacin | 500 mg | Tablet | 1x10's | 043500 | PKR 371.69 | PKR 37.17/tablet | 🔒 Pharma Pro |
| Ciprojan | Ciprofloxacin | 500 mg | Tablet | 10x10's | 043500 | PKR 2,850.10 | PKR 28.50/tablet | 🔒 Pharma Pro |
| Ciprojan | Ciprofloxacin | 250 mg/5 mL | Suspension | 60ml | 069248 | PKR 325.72 | PKR 5.43/mL | 🔒 Pharma Pro |
| Ciprojan | Ciprofloxacin | 125 mg/5 mL | Suspension | 60ml | 071450 | PKR 222.36 | PKR 3.71/mL | 🔒 Pharma Pro |
| Ciprojan | Ciprofloxacin | 200 mg/100 mL | IV infusion | 1's | 076973 | PKR 206.49 | PKR 206.49/vial/unit | 🔒 Pharma Pro |
| Cipwell Ophtalmic | Ciprofloxacin | 3 mg/mL | Solution | 5ml | 084888 | PKR 189.46 | PKR 37.89/mL | No comparator |
| Clarin | Loratadine | 10 mg | Tablet | 1x10's | 043607 | PKR 148.70 | PKR 14.87/tablet | 🔒 Pharma Pro |
| Clarin | Loratadine | 10 mg | Tablet | 100's | 043607 | PKR 1,367.21 | PKR 13.67/tablet | 🔒 Pharma Pro |
| Clarin | Loratadine | 5 mg/5 mL | Syrup | 30ml | 049419 | PKR 51.64 | PKR 1.72/mL | 🔒 Pharma Pro |
| Clotrimed | Clotrimazole | 10 % | Vaginal cream | 1's(5gm) | 100879 | PKR 139.71 | — | No comparator |
| Clozin | Clozapine | 25 mg | Tablet | 5x10's | 054150 | PKR 1,651.92 | PKR 33.04/tablet | 🔒 Pharma Pro |
| Clozin | Clozapine | 100 mg | Tablet | 5x10's | 054151 | PKR 3,613.57 | PKR 72.27/tablet | 🔒 Pharma Pro |
| Dasvir | Daclatasvir | 60 mg | Tablet | 28's | 088488 | PKR 9,022.64 | PKR 322.24/tablet | 🔒 Pharma Pro |
All 74 NovaMed Pharmaceuticals brands in Pakistan
- Acinopril Plus Lisinopril · 20 mg tablet
- Alar Artemether · 20 mg tablet
- Alar DS Artemether · 40 mg tablet
- Alar Once Artemether · 80 mg tablet
- Alar Plus Artemether · 40 mg tablet
- Aldezole Metronidazole · 500 mg/100 mL infusion
- Amilip Amlodipine · 10 mg tablet, 5 mg tablet
- Arithro Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg injection
- B-Loc Atenolol · 100 mg tablet, 25 mg tablet, 50 mg tablet
- Babic Cephalexin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- Cefcin Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Ciprojan Ciprofloxacin · 125 mg/5 mL suspension, 200 mg/100 mL infusion, 250 mg tablet
- Cipwell Ophtalmic Ciprofloxacin · 3 mg/mL solution
- Clarin Loratadine · 10 mg tablet, 5 mg/5 mL syrup
- Clotrimed Clotrimazole · 10 % cream
- Clozin Clozapine · 100 mg tablet, 25 mg tablet
- Dasvir Daclatasvir · 60 mg tablet
- Declocine Doxycycline · 100 mg capsule
- Enta-B Entecavir · 0.5 mg tablet
- Fer-P Iron polymaltose complex · 50 mg/5 mL syrup
- Fer-P Plus Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet
- Fitem Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- Fosbir Sofosbuvir · 90 mg tablet
- Gempaz Empagliflozin · 10 mg tablet, 25 mg tablet
- Genops Gentamicin · 0.3 % drops
- Glazid MR Gliclazide · 30 mg tablet, 60 mg tablet
- Glimin Gliclazide · 80 mg tablet
- Glimin Forte Gliclazide · 160 mg tablet
- Ibofen Ibuprofen · 100 mg/5 mL suspension, 400 mg/100 mL infusion
- Icef Cefixime · 200 mg capsule
- Iohex 350 Iohexol · 350 mg iodine/mL injection, 755 mg/mL (equiv. iodine 350 mg/mL) injection
- Ironone Iron polymaltose complex, Polysaccharide iron complex · 150 mg capsule, 217.4 mg/5 mL syrup
- Lamidin Lamivudine · 100 mg tablet
- Letam Levetiracetam · 500 mg/5 mL injection
- Lignox Lidocaine · 20 mg/mL injection
- Limet Linezolid · 200 mg infusion
- Linzod Linezolid · 200 mg/100 mL infusion, 400 mg tablet, 600 mg tablet
- Lyvial 200 Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- Maxlox Moxifloxacin · 400 mg tablet
- Merenium Meropenem · 1 g injection, 500 mg injection
- Murocen Mupirocin · 2% ointment
- Nov-C Ascorbic acid · 500 mg tablet
- Novaterafine Terbinafine · 1 % cream
- Novaxone Ceftriaxone · 2 g injection
- Nufex Paediatric (Granules Cephalexin · 100 mg drops
- O-Zole Omeprazole · 20 mg capsule, 40 mg capsule, 40 mg injection
- Ofene Clomifene citrate · 50 mg tablet
- Omixim Cefixime · 200 mg tablet
- Onamed Fluconazole · 100 mg/50 mL infusion, 150 mg capsule
- Oxefab Fluoxetine · 20 mg capsule
- Oxylevo Levofloxacin · 250 mg tablet, 500 mg tablet
- Pedisafe Zinc · 20 mg/5 mL syrup
- Pixcito Apixaban · 2.5 mg tablet, 5 mg tablet
- Provanol Propranolol · 10 mg tablet, 40 mg tablet
- Pure-XIM Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Quilynn-H Hydroxychloroquine · 200 mg tablet
- Riba Ribavirin · 400 mg tablet, 600 mg tablet
- Salazin Silver sulfadiazine · 1 % cream, 10 mg/g (1%) cream
- Scibs Permethrin · 5% cream
- Seaclop Clopidogrel · 75 mg tablet
- Sim-Still Simvastatin · 10 mg tablet, 20 mg tablet
- Sofonil Sofosbuvir · 400 mg tablet
- Sofonil Plus Sofosbuvir + Velpatasvir · 400 mg + 100 mg tablet
- Sunvit Cholecalciferol · 5 mg injection, 5 mg/mL injection
- Supamol Paracetamol · 120 mg/5 mL suspension, 500 mg tablet
- Supamol DS Paracetamol · 250 mg/5 mL suspension
- Swiflin Cefazolin · 1 g injection, 250 mg injection, 500 mg injection
- Taboxa Rivaroxaban · 10 mg tablet, 15 mg tablet, 2.5 mg tablet
- Telday Plus Telmisartan + Amlodipine · 40 mg + 10 mg tablet, 40 mg + 5 mg tablet, 80 mg + 10 mg tablet
- Traxart Tranexamic acid · 500 mg/5 mL injection
- Tucana Cefixime · 100 mg/5 mL suspension, 200 mg/5 mL suspension, 400 mg capsule
- Virjox Tenofovir disoproxil · 300 mg tablet, 300 mg (equivalent to tenofovir disoproxil 245 mg) tablet
- Water for Injection Water for Injection · 10 mL injection, 5 mL injection
- Zygrel Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg capsule
NovaMed Pharmaceuticals: common questions
How many products does NovaMed Pharmaceuticals have in Pakistan?
NovaMed Pharmaceuticals(Pvt.)Ltd has 185 registered medicine presentations in Pakistan, sold under 74 brands and covering 61 generic medicines.
What are the main brands of NovaMed Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Taboxa (Rivaroxaban), Ciprojan (Ciprofloxacin), O-Zole (Omeprazole), Arithro (Clarithromycin) and Cefcin (Ceftriaxone). This is not a sales ranking.
Which therapy areas does NovaMed Pharmaceuticals cover?
The most products are in Anti-infectives (94), Cardiovascular (20), Hematology & thrombosis (16), Vitamins, minerals & nutrition (12) and Endocrine & metabolic (11).
Where can I see NovaMed Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.
